Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$25.79 USD
+0.49 (1.94%)
Updated May 21, 2024 04:00 PM ET
After-Market: $25.80 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | -35.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.39 |
Next Year | 0.12 |
EPS (TTM) | -2.69 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 75.09M | 82.05M | 315.91M | 413.11M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 77.35M | 85.37M | 318.80M | 482.83M |
Low Estimate | 73.27M | 79.80M | 312.71M | 381.80M |
Year ago Sales | 37.50M | 47.73M | 186.37M | 315.91M |
Year over Year Growth Est. | 100.24% | 71.90% | 69.50% | 30.77% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.27 | -1.39 | 0.12 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.54 | -0.33 | -1.65 | 1.79 |
High Estimate | 0.06 | 0.16 | 0.51 | 2.21 |
Low Estimate | -0.67 | -0.44 | -2.06 | -1.97 |
Year ago EPS | -0.92 | -0.57 | -3.94 | -1.39 |
Year over Year Growth Est. | 52.17% | 52.63% | 64.72% | 108.87% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 3 | 2 |
Up Last 60 Days | 0 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 5 | 5 | 4 | 4 |
Down Last 60 Days | 5 | 5 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.27 | -1.39 | 0.12 |
7 Days Ago | -0.44 | -0.27 | -1.39 | 0.12 |
30 Days Ago | -0.33 | -0.25 | -1.29 | 0.63 |
60 Days Ago | -0.24 | -0.20 | -1.12 | 1.08 |
90 Days Ago | -0.02 | -0.01 | -0.18 | 1.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.44 | -0.27 | -1.39 | 0.12 |
Zacks Consensus Estimate | -0.44 | -0.27 | -1.39 | 0.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.66 | -0.57 | -0.92 | NA |
Estimate | -0.40 | -0.34 | -0.64 | -0.81 | NA |
Difference | -0.14 | -0.32 | 0.07 | -0.11 | -0.13 |
Surprise | -35.00% | -94.12% | 10.94% | -13.58% | -32.94% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more